Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma

被引:67
作者
Bei, R
Pompa, G
Vitolo, D
Moriconi, E
Ciocci, L
Quaranta, M
Frati, L
Kraus, MH
Muraro, R
机构
[1] Univ G DAnnunzio, Dipartimento Oncol & Neurosci, I-66013 Chieti, Italy
[2] Univ Roma La Sapienza, Dept Dent, Rome, Italy
[3] Ist Mediterraneo Neuromed, Pozzilli, Italy
[4] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
关键词
oral cavity; squamous cell carcinoma; EGFR; ErbB2; ErbB3; ErbB4; receptors; co-expression;
D O I
10.1002/path.965
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of all four ErbB receptors was compared by immunohistochemistry, using receptor-specific polyclonal antisera, in 32 invasive, 11 in situ carcinomas, six benign lesions, and 22 samples of histologically normal mucosa adjacent to specimens of carcinoma originating from oral cavity epithelium. Among invasive and in situ carcinoma, EGFR expression was the most prevalent (in 29/32 and 8/11 cases, respectively) followed by ErbB2 (17/32 and 2/11) and ErbB4 (9/32 and 1/10), while ErbB3 was only detected in invasive tumours (12/32). Specific patterns included invasive tumours with expression of EGFR (8/32) or ErbB4 (1/32) alone, as well as different receptor combinations (EGFR + ErbB2, EGFR + ErbB4, EGFR + ErbB2 + ErbB3, EGFR + ErbB2 + ErbB4, and all four receptors). Simultaneous expression of three or four ErbB receptors correlated with tumour invasion (p = 2.2 x 10(-4)) and localized in the intermediate epithelial cell layer of well and moderately differentiated tumours. No other significant correlation with clinico-pathological features was noticed. Some benign lesions and histologically normal mucosa adjacent to carcinomas showed weak immunostaining of EGFR (10/28), ErbB2 (4/28) or ErbB4 (3/28). By comparison, overexpression, as indicated by increased staining intensity, was observed in invasive tumours for EGFR (18/32), ErbB2 (8/32), ErbB4 (3/32), and ErbB3 (3/32). Statistical evaluation demonstrated a significant association of EGFR or ErbB2 overexpression with invasive carcinoma when compared with benign lesions and apparently normal epithelium (p=5.2 x 10(-7) and p=5 x 10(-3) respectively). Tumour-specific overexpression of ErbB receptors and their co-expression, most frequently involving EGFR and ErbB2, in the same cell layer of neoplastic epithelium, implicate receptor heterodimers in the pathogenesis of oral squamous carcinoma. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 28 条
[1]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[2]   Immune responses to all ErbB family receptors detectable in serum of cancer patients [J].
Bei, R ;
Masuelli, L ;
Moriconi, E ;
Visco, V ;
Moretti, A ;
Kraus, MH ;
Muraro, R .
ONCOGENE, 1999, 18 (06) :1267-1275
[3]   A NEU ACQUAINTANCE FOR ERBB3 AND ERBB4 - A ROLE FOR RECEPTOR HETERODIMERIZATION IN GROWTH SIGNALING [J].
CARRAWAY, KL ;
CANTLEY, LC .
CELL, 1994, 78 (01) :5-8
[4]   Expression and function of EGF-related peptides and their receptors in gynecological cancer - From basic science to therapy? [J].
Ebert, AD ;
Wechselberger, C ;
Martinez-Lacaci, I ;
Bianco, C ;
Weitzel, HK ;
Salomon, DS .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2000, 20 (01) :1-46
[5]   EFFICIENT COUPLING WITH PHOSPHATIDYLINOSITOL 3-KINASE, BUT NOT PHOSPHOLIPASE C-GAMMA OR GTPASE-ACTIVATING PROTEIN, DISTINGUISHES ERBB-3 SIGNALING FROM THAT OF OTHER ERBB EGFR FAMILY MEMBERS [J].
FEDI, P ;
PIERCE, JH ;
DIFIORE, PP ;
KRAUS, MH .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (01) :492-500
[6]   ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling [J].
GrausPorta, D ;
Beerli, RR ;
Daly, JM ;
Hynes, NE .
EMBO JOURNAL, 1997, 16 (07) :1647-1655
[7]   The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer [J].
Gullick, WJ ;
Srinivasan, R .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :43-53
[8]  
Ibrahim SO, 1997, ANTICANCER RES, V17, P4539
[9]  
IRISH JC, 1993, LARYNGOSCOPE, V103, P42
[10]   SYNERGISTIC INTERACTION OF P185C-NEU AND THE EGF RECEPTOR LEADS TO TRANSFORMATION OF RODENT FIBROBLASTS [J].
KOKAI, Y ;
MYERS, JN ;
WADA, T ;
BROWN, VI ;
LEVEA, CM ;
DAVIS, JG ;
DOBASHI, K ;
GREENE, MI .
CELL, 1989, 58 (02) :287-292